Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
United Therapeutics Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | United Therapeutics Corporation | Option exercise | +130 | $110.86 | $14,412 |
| Sep 14, 2026 | United Therapeutics Corporation | Open-market sale | −130 | $505.79 | $65,752 |
| Sep 14, 2026 | United Therapeutics Corporation | Open-market sale | −98 | $505.98 | $49,586 |
| Jul 9, 2026 | United Therapeutics Corporation | Option exercise | +650 | — | — |
| May 12, 2026 | United Therapeutics Corporation | Open-market sale | −258 | $581.94 | $150,141 |
| Dec 9, 2025 | United Therapeutics Corporation | Open-market sale | −187 | $481.63 | $90,065 |
| Jul 25, 2025 | United Therapeutics Corporation | Option exercise | +590 | — | — |
| Jun 24, 2025 | United Therapeutics Corporation | Open-market sale | −645 | $289.99 | $187,044 |
| Dec 30, 2024 | United Therapeutics Corporation | Open-market sale | −255 | $355.77 | $90,721 |
| Nov 8, 2024 | United Therapeutics Corporation | Open-market sale | −224 | $412.28 | $92,351 |
| Jul 13, 2024 | United Therapeutics Corporation | Option exercise | +900 | — | — |
| Jun 25, 2024 | United Therapeutics Corporation | Open-market sale | −266 | $318.58 | $84,742 |
| Mar 27, 2024 | United Therapeutics Corporation | Open-market sale | −325 | $237.80 | $77,285 |
| Dec 19, 2023 | United Therapeutics Corporation | Open-market sale | −605 | $244.90 | $148,165 |
| Sep 13, 2023 | United Therapeutics Corporation | Open-market sale | −383 | $222.36 | $85,164 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.